Grace Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 13/08/2026 | Dec 2025Filed 12/02/2026 | Sep 2025Filed 12/02/2026 | Jun 2025Filed 13/08/2026 | Dec 2024Filed 12/02/2026 | Sep 2024Filed 12/02/2026 | Jun 2024Filed 12/02/2026 | Dec 2023Filed 13/02/2025 |
|---|---|---|---|---|---|---|---|---|
| −$16 | −$2.3 | −$0.9 | −$3.4 | −$4.2 | −$3.4 | −$2.6 | −$2.4 | |
| −$0.91 | −$0.14 | −$0.06 | −$0.21 | −$0.36 | −$0.30 | −$0.24 | −$0.21 | |
| 17 | 17 | 16 | 16 | 12 | 12 | 11 | 12 |
Trend